Showing 1–50 of 97 results
-
Comments and Opinion |
Towards data-driven next-generation transmission electron microscopy
- Steven R. Spurgeon
- , Colin Ophus
- , Lewys Jones
- , Amanda Petford-Long
- , Sergei V. Kalinin
- , Matthew J. Olszta
- , Rafal E. Dunin-Borkowski
- , Norman Salmon
- , Khalid Hattar
- , Wei-Chang D. Yang
- , Renu Sharma
- , Yingge Du
- , Ann Chiaramonti
- , Haimei Zheng
- , Edgar C. Buck
- , Libor Kovarik
- , R. Lee Penn
- , Dongsheng Li
- , Xin Zhang
- , Mitsuhiro Murayama
- & Mitra L. Taheri
-
Research |
-
Research | | Open
-
Amendments and Corrections |
-
Amendments and Corrections |
-
Research |
ATP and spontaneous calcium oscillations control neural stem cell fate determination in Huntington’s disease: a novel approach for cell clock research
- Talita Glaser
- , Hiromi Shimojo
- , Deidiane Elisa Ribeiro
- , Patrícia Pereira Lopes Martins
- , Renata Pereira Beco
- , Michal Kosinski
- , Vanessa Fernandes Arnaud Sampaio
- , Juliana Corrêa-Velloso
- , Ágatha Oliveira-Giacomelli
- , Claudiana Lameu
- , Ana Paula de Jesus Santos
- , Héllio Danny Nóbrega de Souza
- , Yang D. Teng
- , Ryoichiro Kageyama
- & Henning Ulrich
-
Research | | Open
-
Research |
-
Research |
-
Research |
-
Research |
-
Research |
-
Research |
-
Research |
-
Research |
Prospective study of EGFR intron 1 (CA)n repeats variants as predictors of benefit from cetuximab and irinotecan in chemo-refractory metastatic colorectal cancer (mCRC) patients
- F Loupakis
- , C Antoniotti
- , C Cremolini
- , W Zhang
- , D Yang
- , T Wakatsuki
- , P Bohanes
- , M Schirripa
- , L Salvatore
- , G Masi
- , V Ricci
- , F Graziano
- , A Ruzzo
- , L Benhaim
- , F Marmorino
- , Y Ning
- , R El-Khoueiry
- , A Falcone
- & H-J Lenz
The Pharmacogenomics Journal 14 , 322–327 -
-
Research |
-
Research |
-
Research | | Open
-
Research |
-
Research |
-
Research |
-
Research |
-
Research | | Open
-
Research |
-
Research |
-
Research |
-
Research |
-
Research |
-
Amendments and Corrections |
-
Research |
-
Research |
-
Research |
-
-
| Open
-
Research |
Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy
- A Pohl
- , A El-Khoueiry
- , D Yang
- , W Zhang
- , G Lurje
- , Y Ning
- , T Winder
- , S Hu-Lieskoven
- , S Iqbal
- , K D Danenberg
- , M Kahn
- , J-L Teo
- , J Shriki
- , J Stebbing
- & H-J Lenz
The Pharmacogenomics Journal 13 , 173–180 -
Research |
-
Research |
-
Research |
-
Research |
-
-
-
Research |
-
-
Research |
-
Research |
-
-
-
-